Searched over 200M research papers
10 papers analyzed
These studies suggest congenital heart defects are structural abnormalities in the heart or great vessels present at birth, caused by complex genetic mechanisms, and require lifelong specialist follow-up and interdisciplinary care for effective management.
20 papers analyzed
Congenital heart defects (CHD) are structural abnormalities of the heart or great vessels that are present at birth. These defects are the most common type of birth defect, affecting approximately 1% of live births globally . The spectrum of CHD ranges from simple defects, such as septal defects, to more complex structural abnormalities.
The genetic underpinnings of CHD are complex and multifaceted. Known genetic causes include chromosomal aneuploidies, copy number variants, and single-nucleotide variants, which can be either inherited or occur de novo . Approximately 8%-12% of CHD cases are associated with chromosomal abnormalities, 3%-25% with copy number variations, and 3%-5% with single-gene defects. These genetic variations disrupt genes crucial for normal cardiac development, sometimes affecting other organs as well .
Recent advances in genetic engineering, imaging, and omics analyses have significantly enhanced our understanding of the mechanisms behind heart formation and malformation. Despite these advances, around 80% of CHD cases still have an unknown genetic origin. Studies have identified about 400 genes implicated in CHD, including those encoding transcription factors, cell signaling molecules, and structural proteins. Additionally, genes related to chromatin modifiers and cilia-transduced cell signaling pathways have been found to play important roles in CHD pathogenesis.
The clinical presentation of CHD varies widely depending on the specific type of defect. Symptoms can range from harmless to life-threatening and may include rapid breathing, bluish skin (cyanosis), low weight, and fatigue. CHD can lead to complications such as heart failure, necessitating lifelong specialist follow-up and potential re-interventions .
CHD can be detected both prenatally and postnatally. Advances in diagnostic techniques, including imaging and genetic testing, have improved early detection and management of these defects. A timely diagnosis is crucial for risk stratification, surveillance of associated conditions, and family planning.
Most individuals with CHD require surgical corrections or percutaneous catheter treatments to address structural defects. Advances in surgical and perioperative care have significantly improved survival rates, allowing over 85% of children with CHD to survive into adulthood . However, many patients are left with residual structural defects, valve lesions, or ventricular dysfunction, necessitating ongoing specialist care.
A comprehensive care approach is essential for managing CHD, encompassing regular cardiac check-ups, appropriate drug treatments, surgical interventions, rehabilitation, psychological support, and education for patients and their families. This holistic approach aims to improve the quality of life and long-term outcomes for individuals with CHD.
Congenital heart defects are the most common birth defects, with a complex genetic basis and a wide range of clinical manifestations. Advances in genetic research and diagnostic techniques have improved our understanding and management of CHD, but many challenges remain. A multidisciplinary approach is essential for providing optimal care and improving outcomes for patients with CHD.
Most relevant research papers on this topic